Clinical Trial Update: Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures [NA]

View source ↗

Summary

The clinical trial evaluating Kerecis Omega-3 for leg ulcers was withdrawn. Sponsored by Insel Gruppe AG and University Hospital Bern.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leg Ulcer

Drugs mentioned

• Kerecis Omega-3 (Omega-3 fish skin graft)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Leg Ulcer | NA | Status: WITHDRAWN